|
|
|
|
|
|||||||
|
Session 95
Poster Session
Organ Specific Toxicities/Complications 4:30-6:30 pm 4E-F |
to view the poster for an abstract. to view the poster for an abstract.| 719-T. | Neuropsychiatric Complications of Efavirenz (EFV): Results of a Randomized Prospective Comparison with Nelfinavir (NFV) in Antiretroviral (ARV)-Naïve Patients D. Dorfman*1, A. Chu2, R. Haubrich3, M. Naseer1, C. Petersen4, J. Schmeidler1, and D. Simpson1 1Mount Sinai Sch. of Med., New York, NY; 2Pfizer, La Jolla, CA; 3Univ. of California, San Diego; and 4Agouron Pharmaceuticals, Inc., La Jolla, CA
| ||
| 720-T. | CNS Side Effects as Main Risk Factor for Efavirenz Failure and Transient HIV-RNA Elevation M. Zaccarelli*, F. Soldani, G. Liuzzi, P. Sette, S. Grisetti, M. P. Trotta, C. F. Perno, and A. Antinori Natl. Inst. for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy
| ||
| 721-T. | Risk of Nephrolithiasis in HIV+ Patients Receiving Indinavir in 6 Randomized Controlled Clinical Trials J. Chen*, M. Nessly, R. Leavitt, B. Y. Nguyen, and L. Gilde Merck Res. Labs., West Point, PA
| ||
| 722-T. | Renal Abnormalities as Predictors of Hospitalization in a Prospective Multi-Center Cohort Study of HIV-Positive Women L. Gardner*1, S. Holmberg1, K. Tashima2, P. Schuman3, A. Romaplo4, R. Sadek1, and R. Klein5 1CDC, Atlanta, GA; 2Brown Univ., Providence, RI; 3Wayne State Univ. Sch. of Med., Detroit, MI; 4Johns Hopkins Univ. Sch. of Hygiene and Publ. Hlth., Baltimore, MD; and 5Montefiore Med. Ctr. and Albert Einstein Coll. of Med., Bronx, NY
| ||
| 723-T. | Hepatic Adverse Events Associated with Delavirdine (DLV): Results of Multiple Clinical Trials D. Dieterich*1, A. Chu2, and C. Petersen2 1Cabrini Med. Ctr., New York Univ. Sch. of Med., New York; and 2Pfizer/Agouron Pharmaceuticals, La Jolla, CA
| ||
| 724-T. | Hepatotoxicity among a Cohort of Thai HIV-Infected Patients Enrolled in HIV-NAT Antiretroviral Therapy Trials P. Law*1, G. Dore1, C. Duncombe1, M. Law1, J. Lange2, P. Phanuphak3, and D. A. Cooper1 1Natl. Ctr. in HIV Epidemiology and Clin. Res., Univ. of New South Wales, Australia; 2Natl. AIDS Therapy Evaluation Ctr., Univ. of Amsterdam, The Netherlands; and 3Thai Red Cross AIDS Res. Ctr., Bangkok
| ||
| 725-T. | Sexual Disturbances in HIV-Infected Patients under Highly Active Antiretroviral Therapy J. Collazos*, E. Martínez, J. Mayo, and S. Ibarra Hosp. de Galdácano, Vizcaya, Spain
| ||
| 726-T. | Metabolic and Immunologic Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis F. García, M. Plana, G. Mestre, A. Cruceta, E. Martinez, J. Mallolas, J. Miró, M. Tuset, T. Pumarola, T. Gallart, and J. M. Gatell* Inst. Clin. d’Infeccions i Immunologia, Hosp. Clin.-IDIBAPS; Univ. of Barcelona, Spain
|
